{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:24:29Z","timestamp":1763036669906},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1212\/wnl.45.3.487","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:14:59Z","timestamp":1336914899000},"page":"487-492","update-policy":"http:\/\/dx.doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":43,"title":["Acanthocytosis, Retinitis Pigmentosa, and Pallidal Degeneration"],"prefix":"10.1212","volume":"45","author":[{"given":"R. W.","family":"Orrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. J.","family":"Amrolia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Heald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. G.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Morgan-Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. D.","family":"Marsden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"7","volume":"30","year":"1974","unstructured":"Dooling EC, Schoene WC, Richardson EP. Hallervorden-Spatz syndrome. Arch Neurol 1974;30:70-83.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.1.1"},{"key":"e_1_3_1_4_2","first-page":"2","volume":"76","year":"1985","unstructured":"Owen JS, Brown DJC, Harry DS, et al. Erythrocyte echinocytosis in liver disease: role of abnormal plasma high density lipoproteins. J Clin Invest 1985;76:2275-2285.","journal-title":"J Clin Invest"},{"key":"e_1_3_1_5_2","first-page":"1","volume":"23","year":"1982","unstructured":"Owen JS, Bruckdorfer KR, Day RC, McIntyre N. Decreased erythrocyte membrane fluidity and altered lipid composition in human liver disease. J Lipid Res 1982;23:124-132.","journal-title":"J Lipid Res"},{"key":"e_1_3_1_6_2","first-page":"1","volume":"25","year":"1979","unstructured":"Papadopoulos NM. Abnormal lipoprotein patterns in human serum as determined by agarose gel electrophoresis. Clin Chem 1979;25:1885-1887.","journal-title":"Clin Chem"},{"key":"e_1_3_1_7_2","first-page":"9","volume":"25","year":"1984","unstructured":"Owen JS, Goodall H, Mistry P, Harry DS, Day RC, McIntyre N. Abnormal high density lipoproteins from patients with liver disease regulate cholesterol metabolism in cultured human skin fibroblasts. J Lipid Res 1984;25:919-931.","journal-title":"J Lipid Res"},{"key":"e_1_3_1_8_2","first-page":"8","volume":"9","year":"1989","unstructured":"Krul ES, Kinoshita M, Talmud P, et al. Two distinct truncated apolipoprotein B species in a kindred with hypobetalipoproteinemia. Arteriosclerosis 1989;9:856-868.","journal-title":"Arteriosclerosis"},{"key":"e_1_3_1_9_2","first-page":"1","volume":"114","year":"1991","unstructured":"Hardie RJ, Pullon HWH, Harding AE, et al. Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases. Brain 1991;114:13-49.","journal-title":"Brain"},{"key":"e_1_3_1_10_2","first-page":"2","volume":"79","year":"1922","unstructured":"Hallervorden J, Spatz H. Eigenartige Erkrankung im extrapyramidalen System mit besonderer Beteiligung des Globus pallidus und der Substantia nigra. Z Neurol Psychiat 1922;79:254-302.","journal-title":"Z Neurol Psychiat"},{"key":"e_1_3_1_11_2","first-page":"3","volume":"8","year":"1987","unstructured":"Rutledge JN, Hilal SK, Silver AJ, Defendini R, Fahn S. Study of movement disorders and brain iron by MR. AJNR 1987;8:397-411.","journal-title":"AJNR"},{"key":"e_1_3_1_12_2","first-page":"6","volume":"24","year":"1988","unstructured":"Sethi KD, Adams RJ, Loring DW, El Gammal T. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol 1988;24:692-694.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_13_2","first-page":"4","volume":"39","year":"1989","unstructured":"Schaffert DA, Johnsen SD, Johnson PC, Drayer BP. Magnetic resonance imaging in pathologically proven Hallervorden-Spatz disease. Neurology 1989;39:440-442.","journal-title":"Neurology"},{"key":"e_1_3_1_14_2","first-page":"2","volume":"16","year":"1971","unstructured":"Roth AM, Hepler RS, Mukoyama M, Cancilla PA, Foos RY. Pigmentary retinal dystrophy in Hallervorden-Spatz disease: clinicopathological report of a case. Surv Ophthalmol 1971;16:24-35.","journal-title":"Surv Ophthalmol"},{"key":"e_1_3_1_15_2","first-page":"2","volume":"97","year":"1972","unstructured":"Swisher CN, Menkes JH, Cancilla PA, Dodge PR. Coexistence of Hallervorden-Spatz disease with acanthocytosis. Trans Am Neurol Assoc 1972;97:212-216.","journal-title":"Trans Am Neurol Assoc"},{"key":"e_1_3_1_16_2","first-page":"3","volume":"95","year":"1983","unstructured":"Luckenbach MW, Green WR, Miller NR, Moser HW, Clark AW, Tennekoon G. Ocular clinicopathologic correlation of Hallervorden-Spatz syndrome with acanthocytosis and pigmentary retinopathy. Am J Ophthalmol 1983;95:369-382.","journal-title":"Am J Ophthalmol"},{"key":"e_1_3_1_17_2","first-page":"6","volume":"137","year":"1989","unstructured":"Kohler B. Hallervorden-Spatz Syndrom mit Akanthozytose. Monatsschr Kinderheilkd 1989;137:616-619.","journal-title":"Monatsschr Kinderheilkd"},{"key":"e_1_3_1_18_2","unstructured":"Siddique T Fredane L Papadopoulos N Clarke P Greibel M Vance J. Neuroacanthocytosis with low apoproteinbeta and absent pre-beta lipoprotein: a new disorder or a new finding? (abstract). Neurology 1987;37(suppl 1):139."},{"key":"e_1_3_1_19_2","first-page":"3","volume":"40","year":"1972","unstructured":"Brecher G, Bessis M. Present status of spiculed red cells and their relationship to the discocyte-echinocyte transformation: a critical review. Blood 1972;40:333-344.","journal-title":"Blood"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.1.1"},{"key":"e_1_3_1_21_2","first-page":"4","volume":"31","year":"1977","unstructured":"Kudo A, Tanaka N, Oogaki S, Niimura T, Kanehisa T. Hypobetalipoproteinaemia with abnormal prebetalipoprotein. J Neurol Sci 1977;31:411-419.","journal-title":"J Neurol Sci"},{"key":"e_1_3_1_22_2","first-page":"1","volume":"46","year":"1992","unstructured":"Angelin B, Rudling M. Molecular aspects of human metabolism. Eur J Clin Nutr 1992;46:153-160.","journal-title":"Eur J Clin Nutr"},{"key":"e_1_3_1_23_2","first-page":"2","volume":"109","year":"1986","unstructured":"Schmickel RD. Contiguous gene syndromes: a component of recognizable syndromes. J Pediatr 1986;109:231-241.","journal-title":"J Pediatr"},{"key":"e_1_3_1_24_2","unstructured":"Emmanuel BS. Molecular cytogenetics: toward dissection of the contiguous gene syndromes. Am J Hum Genet 1988;43: 575-578."},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","unstructured":"Dunger DB Davies KE Pembrey M et al. Deletion on the X chromosome detected by direct DNA analysis in one of two unrelated boys with glycerol kinase deficiency adrenal hypoplasia and Duchenne muscular dystrophy. Lancet 1986;1: 585-587.","DOI":"10.1016\/S0140-6736(86)92811-4"},{"key":"e_1_3_1_26_2","first-page":"8","volume":"30","year":"1993","unstructured":"Holder SE, Winter RM, Kamath S, Scambler PJ. Velocardiofacial syndrome in a mother and daughter: variability of the clinical phenotype. J Med Genet 1993;30:825-827.","journal-title":"J Med Genet"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.45.3.487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T16:04:18Z","timestamp":1711641858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.45.3.487"}},"subtitle":["A Report of Three Patients, Including the Second Reported Case With Hypoprebetalipoproteinemia (HARP syndrome)"],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["10.1212\/WNL.45.3.487"],"URL":"https:\/\/doi.org\/10.1212\/wnl.45.3.487","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}